RegMedXB

RegMedXB (Regenerative Medicine Crossing Borders) is a prominent international public-private partnership and virtual institute focused on the advancement of regenerative medicine. Based in the Netherlands and Belgium, the consortium unites leading academic researchers, medical centers, and industrial partners to develop curative therapies for chronic diseases. Its primary moonshot programs target type 1 diabetes, kidney disease, osteoarthritis, and cardiovascular failure through innovative technologies such as stem cell therapy, tissue engineering, and organ-on-a-chip models. By fostering a collaborative ecosystem, RegMedXB aims to bridge the gap between fundamental research and clinical application, accelerating the delivery of life-changing treatments to patients. The organization is supported by significant public funding, including the Dutch National Growth Fund, and operates as a non-profit foundation.